The impact of the muscle mass-to-fat ratio on the prognosis of patients undergoing pancreaticoduodenectomy for pancreatic cancer

被引:0
|
作者
Xu, Long-Jie [1 ]
Zhang, Sheng-Qiang [1 ]
Cao, Chun [1 ]
机构
[1] Soochow Univ, Dept Gen Surg, Affiliated Hosp 2, Suzhou 215004, Peoples R China
来源
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES | 2025年 / 41卷 / 02期
基金
中国国家自然科学基金;
关键词
complications; muscle mass-to-fat ratio; overall survival; pancreatic cancer; pancreaticoduodenectomy; SKELETAL-MUSCLE; INFLAMMATION; SARCOPENIA; FISTULA; RISK;
D O I
10.1002/kjm2.12928
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To evaluate the relationship between the muscle mass-to-fat ratio (MMFR) at the third lumbar spine (L3) and overall survival (OS) as well as related complications after pancreaticoduodenectomy (PD) for pancreatic cancer. Patients who underwent PD for pancreatic cancer between March 2017 and May 2023 at the Second Affiliated Hospital of Soochow University were included. Muscle mass and fat content at the L3 were measured by computed tomography. The specific formula that was used to calculate the MMFR was total abdominal muscle area/(subcutaneous adipose tissue area + visceral adipose tissue area), and the optimal cutoff values of the MMFR based on receiver operating characteristic curves were 0.688 for males and 0.382 for females. Patient characteristics were collected, and multivariate analyses were used to evaluate the impact of the MMFR on prognosis. Kaplan-Meier survival curves and log-rank tests were used to compare OS between the high-MMFR and low-MMFR groups. On the basis of the optimal cutoff values, 191 patients were divided into two groups, with 91 patients in the low-MMFR group and 100 patients in the high-MMFR group. The incidence of POPF was significantly greater in the low-MMFR group than in the high-MMFR group. According to multivariate analysis, the MMFR was an independent factor associated with POPF and OS. Patients with low MMFRs had significantly shorter OS and a greater POPF incidence than did those with high MMFRs. The MMFR is an independent predictor of POPF and affects the OS of patients undergoing PD for pancreatic cancer.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Predicting Pancreatic Fistula in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma
    Hall, B.
    Sleightholm, R.
    Sayles, H.
    Smith, L.
    Are, C.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S127 - S127
  • [22] IMPACT OF POSTOPERATIVE PANCREATIC FISTULA ON THE PROGNOSIS OF PATIENTS UNDERGOING RESECTION FOR PANCREATIC DUCTAL ADENOCARCINOMA
    Sugimoto, Motokazu
    Kobayashi, Shin
    Takahashi, Shinichiro
    Konishi, Masaru
    Gotohda, Naoto
    GASTROENTEROLOGY, 2019, 156 (06) : S1446 - S1446
  • [23] Neoadjuvant Chemoradiation Therapy Is Associated with Adverse Outcomes in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Cancer
    Aziz, Hassan
    Zeeshan, Muhammad
    Jie, Tun
    Maegawa, Felipe B.
    AMERICAN SURGEON, 2019, 85 (11) : 1276 - 1280
  • [24] Independent effect of fat-to-muscle mass ratio at bioimpedance analysis on long-term survival in patients receiving surgery for pancreatic cancer
    Sandini, Marta
    Paiella, Salvatore
    Cereda, Marco
    Angrisani, Marco
    Capretti, Giovanni
    Famularo, Simone
    Giani, Alessandro
    Roccamatisi, Linda
    Fontani, Andrea
    Malleo, Giuseppe
    Salvia, Roberto
    Roviello, Franco
    Zerbi, Alessandro
    Bassi, Claudio
    Gianotti, Luca
    FRONTIERS IN NUTRITION, 2023, 10
  • [25] THE IMPACT OF SKELETAL MUSCLE MASS LOSS IN PATIENTS WITH ADVANCED PANCREATIC CANCER DURING FOLFIRINOX
    Uemura, Shinya
    Iwashita, Takuji
    Ichikawa, Hironao
    Iwasa, Yuhei
    Mita, Naoki
    Shimizu, Masahito
    GASTROENTEROLOGY, 2020, 158 (06) : S863 - S863
  • [26] The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
    Basile, Debora
    Parnofiello, Annamaria
    Vitale, Maria Grazia
    Cortiula, Francesco
    Gerratana, Lorenzo
    Fanotto, Valentina
    Lisanti, Camilla
    Pelizzari, Giacomo
    Ongaro, Elena
    Bartoletti, Michele
    Garattini, Silvio Ken
    Andreotti, Victoria Josephine
    Bacco, Anna
    Iacono, Donatella
    Bonotto, Marta
    Casagrande, Mariaelena
    Ermacora, Paola
    Puglisi, Fabio
    Pella, Nicoletta
    Fasola, Gianpiero
    Aprile, Giuseppe
    Cardellino, Giovanni G.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2019, 10 (02) : 368 - 377
  • [27] Evaluation of the impact of lymph node ratio on survival in patients with pancreatic cancer undergoing neoadjuvant therapy.
    Thomas, Maren
    Huston, Jamie
    Shridhar, Ravi
    Meredith, Kenneth Lee
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [28] Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy
    Ishii, Noriko
    Iwata, Yoshinori
    Nishikawa, Hiroki
    Enomoto, Hirayuki
    Aizawa, Nobuhiro
    Ishii, Akio
    Miyamoto, Yuho
    Yuri, Yukihisa
    Hasegawa, Kunihiro
    Nakano, Chikage
    Nishimura, Takashi
    Yoh, Kazunori
    Sakai, Yoshiyuki
    Ikeda, Naoto
    Takashima, Tomoyuki
    Takata, Ryo
    Iijima, Hiroko
    Nishiguchi, Shuhei
    ONCOLOGY LETTERS, 2017, 14 (05) : 6059 - 6065
  • [29] Neutrophil-to-lymphocyte ratio as an indicator of prognosis in patients with pancreatic cancer
    Kawada, Tomoyuki
    HPB, 2019, 21 (12) : 1791 - 1791
  • [30] Prognostic impact of muscle and fat mass in patients with heart failure
    Konishi, Masaaki
    Akiyama, Eiichi
    Matsuzawa, Yasushi
    Sato, Ryosuke
    Kikuchi, Shinnosuke
    Nakahashi, Hidefumi
    Maejima, Nobuhiko
    Iwahashi, Noriaki
    Kosuge, Masami
    Ebina, Toshiaki
    Hibi, Kiyoshi
    Misumi, Toshihiro
    von Haehling, Stephan
    Anker, Stefan D.
    Tamura, Kouichi
    Kimura, Kazuo
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (03) : 568 - 576